News Test based on natural processes cannot be patented, rules US court BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e2290 (Published 23 March 2012) Cite this as: BMJ 2012;344:e2290 Article Related content Metrics Responses Peer review Related articles News US Supreme Court is asked to rule on validity of patents on BRCA1 and BRCA2 genes Published: 02 October 2012; BMJ 345 doi:10.1136/bmj.e6624 News Supreme Court will rule on whether patents for BRAC1 and BRAC2 genes are valid Published: 05 December 2012; BMJ 345 doi:10.1136/bmj.e8266 See more Frontotemporal dementia BMJ August 06, 2013, 347 f4827; DOI: https://doi.org/10.1136/bmj.f4827 US Supreme Court may have to settle dispute over patenting DNA sequences BMJ September 27, 2011, 343 d6187; DOI: https://doi.org/10.1136/bmj.d6187 Patents on breast cancer genes are illegal and stymie research, say scientists BMJ November 17, 2009, 339 b4899; DOI: https://doi.org/10.1136/bmj.b4899 Techniques and applications of molecular biology BMJ August 26, 2009, 339 b3324; DOI: https://doi.org/10.1136/bmj.b3324 Commentary: Controversies in SIGN guidance on diagnosing and managing headache in adults BMJ November 20, 2008, 337 a2445; DOI: https://doi.org/10.1136/bmj.a2445 Cited by... Supreme Court will rule on whether patents for BRAC1 and BRAC2 genes are validFulltext PDF US Supreme Court is asked to rule on validity of patents on BRCA1 and BRCA2 genesFulltext PDF
